Clinical Trial Update: Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults [Phase 2]

View source ↗

Summary

Phase II clinical trial of JT002 for Seasonal Allergic Rhinitis in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• JT002

Snippet

Sponsor: Shanghai JunTop Biosciences Co., LTD | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED